title: Feasibility, phase I, and pharmacological study of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced malignancies in the lungs.
authors.affiliation: Section of Gynecologic Medical Therapeutics, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 401, Houston, Texas 77030, USA. cverschr@mdanderson.org
authors.forename: C F
authors.initials: CF
authors.lastname: Verschraegen
authors.forename: B E
authors.initials: BE
authors.lastname: Gilbert
authors.forename: A J
authors.initials: AJ
authors.lastname: Huaringa
authors.forename: R
authors.initials: R
authors.lastname: Newman
authors.forename: N
authors.initials: N
authors.lastname: Harris
authors.forename: F J
authors.initials: FJ
authors.lastname: Leyva
authors.forename: L
authors.initials: L
authors.lastname: Keus
authors.forename: K
authors.initials: K
authors.lastname: Campbell
authors.forename: T
authors.initials: T
authors.lastname: Nelson-Taylor
authors.forename: V
authors.initials: V
authors.lastname: Knight
mesh_terms: D000328:Adult; D000336:Aerosols; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D002166:Camptothecin / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D004334:Drug Administration Schedule; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008081:Liposomes; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D008875:Middle Aged
chemical_list: D000336:Aerosols; D000970:Antineoplastic Agents; D008081:Liposomes; C079905:rubitecan; D002166:Camptothecin